These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
161 related items for PubMed ID: 21642381
1. The efficacy of IGF-I receptor monoclonal antibody against human gastrointestinal carcinomas is independent of k-ras mutation status. Ii M, Li H, Adachi Y, Yamamoto H, Ohashi H, Taniguchi H, Arimura Y, Carbone DP, Imai K, Shinomura Y. Clin Cancer Res; 2011 Aug 01; 17(15):5048-59. PubMed ID: 21642381 [Abstract] [Full Text] [Related]
2. Growth-inhibitory effects of human anti-insulin-like growth factor-I receptor antibody (A12) in an orthotopic nude mouse model of anaplastic thyroid carcinoma. Wang Z, Chakravarty G, Kim S, Yazici YD, Younes MN, Jasser SA, Santillan AA, Bucana CD, El-Naggar AK, Myers JN. Clin Cancer Res; 2006 Aug 01; 12(15):4755-65. PubMed ID: 16899627 [Abstract] [Full Text] [Related]
3. The effect of forced expression of mutated K-RAS gene on gastrointestinal cancer cell lines and the IGF-1R targeting therapy. Matsunaga Y, Adachi Y, Sasaki Y, Koide H, Motoya M, Nosho K, Takagi H, Yamamoto H, Sasaki S, Arimura Y, Tokino T, Carbone DP, Imai K, Shinomura Y. Mol Carcinog; 2017 Feb 01; 56(2):515-526. PubMed ID: 27312358 [Abstract] [Full Text] [Related]
10. Targeting for insulin-like growth factor-I receptor with short hairpin RNA for human digestive/gastrointestinal cancers. Wang Y, Adachi Y, Imsumran A, Yamamoto H, Piao W, Li H, Ii M, Arimura Y, Park MY, Kim D, Lee CT, Carbone DP, Imai K, Shinomura Y. J Gastroenterol; 2010 Feb 01; 45(2):159-70. PubMed ID: 19902140 [Abstract] [Full Text] [Related]
13. Targeting of insulin-like growth factor-I receptor with a monoclonal antibody inhibits growth of hepatic metastases from human colon carcinoma in mice. Bauer TW, Fan F, Liu W, Camp ER, Yang A, Somcio RJ, Bucana CD, Singh R, Ellis LM. Ann Surg Oncol; 2007 Oct 01; 14(10):2838-46. PubMed ID: 17653802 [Abstract] [Full Text] [Related]
14. Insulin-like growth factor-I receptor signaling blockade combined with radiation. Allen GW, Saba C, Armstrong EA, Huang SM, Benavente S, Ludwig DL, Hicklin DJ, Harari PM. Cancer Res; 2007 Feb 01; 67(3):1155-62. PubMed ID: 17283150 [Abstract] [Full Text] [Related]
15. Insulin-like growth factor receptor as a therapeutic target in head and neck cancer. Barnes CJ, Ohshiro K, Rayala SK, El-Naggar AK, Kumar R. Clin Cancer Res; 2007 Jul 15; 13(14):4291-9. PubMed ID: 17634559 [Abstract] [Full Text] [Related]
17. Inhibition of hepatocellular carcinoma cell growth by an anti-insulin-like growth factor-I receptor monoclonal antibody. Yue L, Wang Y, Wang H, Gao H, Liang J, Sui A, Xiang J, Zhou F, Xu C, Zhao W, Liang W, Yao R. Oncol Rep; 2012 Oct 15; 28(4):1453-60. PubMed ID: 22895605 [Abstract] [Full Text] [Related]
18. Id1-induced IGF-II and its autocrine/endocrine promotion of esophageal cancer progression and chemoresistance--implications for IGF-II and IGF-IR-targeted therapy. Li B, Tsao SW, Chan KW, Ludwig DL, Novosyadlyy R, Li YY, He QY, Cheung AL. Clin Cancer Res; 2014 May 15; 20(10):2651-62. PubMed ID: 24599933 [Abstract] [Full Text] [Related]
19. Inhibition of insulin-like growth factor 1 receptor by CP-751,871 radiosensitizes non-small cell lung cancer cells. Iwasa T, Okamoto I, Suzuki M, Hatashita E, Yamada Y, Fukuoka M, Ono K, Nakagawa K. Clin Cancer Res; 2009 Aug 15; 15(16):5117-25. PubMed ID: 19671857 [Abstract] [Full Text] [Related]